Introduction

Shanghai Unionlab Co., Ltd (Unionlab) was founded in 2017. The headquartered based on Shanghai. Unionlab focuses on innovative oncology drug. We deliver an integrated service from the strategy to implementation, including Strategy Consultation, Medical Affairs, Clinical Study Operation, Third-party Independent Imaging Review, a Central Laboratory, Data Management, Bioanalysis, FSP and other service. Unionlab's mission is to provide an efficient clinical research service through the use of information-based, smart technology to satisfy the requirements of the clinical development of new drugs, rapid trial and error, dynamic decision-making, high quality, and low cost. Unionlab’s team member over 500. The Unionlab team has responsible for over dozens of clinical trial of innovation drugs, including Antibody, ADCs, micromolecule Targeted Therapies, and others.


Yaoyan Intelligent is the subsidiary company of Unionlab. Yaoyan Intelligent is a digitized, embedded SMO. Yaoyan Intelligent has independently developed a multicenter collaborative smart clinical research system (eDISC) and has helped clinical research centers increase their operation efficiency through AI, big data, and e-Cloud technology. eDISC is operating online in many centers from so far, and it is planned to be deliver it to 30+ hospitals and operating on networks in 2022. Through the layout of the system, we have gradually brought about the digital, smart, platform-based operation in the phase I expansion period of new drug and key clinical studies period. That make truly the faster, better and manageable costs in transform of new drug clinical trial.



Where did Unionlab originate from?

『唯天下至圣,为能聪明睿知,足以有临也。』

——The Doctrine of the Mean, Part 31

Company Career

Milestone

  • Jan 2017

    Unionlab was established

    Provided medical and clinical operation services

  • Jan 2017

    Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of colorectal cancer

  • Jun 2017

    Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of malignant lymphoma

  • Jul 2017

    Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of advanced stomach cancer

  • Aug 2017

    Completed the first subject enrolment for a phase I study in the treatment of colorectal cancer.

  • Dec 2017

    Completed bioanalysis laboratory

    Developed the IRC and patient recruitment service

  • Jan 2018

    Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of solid tumors

  • Mar 2018

    Signed a cooperation agreement with a sponsor to complete a pharmacokinetic clinical study

    Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of malignant tumors

  • May 2018

    Developed data management and stats business

  • Jul 2018

    Signed the first IRC service project

  • Sep 2019

    Developed eDISC system

  • Oct 2018

    The big-data clinical research system clinIQ goes online

  • Nov 2018

    Signed the first CRO phase III service project

  • Jan 2019

    Launched the investigator meeting of whole country for phase III research in the treatment of HCC

  • Feb 2019

    The independent radiology review committee (IRC) system U-Orbit V1.0 goes online

  • Apr 2019

    Signed the first master service agreement for independent imaging review services for clinical trials

  • May 2019

    Signed an agreement for the first IRC service project (phase II follicular lymphoma, IRWG criteria)

    The smart multicenter clinical research system, eDISC, is launched and implemented in a domestic leading research center for new drugs for early-stage tumors

  • Jul 2019

    The Guangzhou and Beijing branches are officially opened and runed 

    Signed the agreement for an NSCLC project. Signed the agreement for a phase III TNBC project, For the first time the phase III project has been completed. Clinical Research Center Training. Image review specialist training, Union Image provides its first batch of phase III deliverable documents to a sponsor.

  • Aug 2019

    Signed a cooperation agreement with a sponsor to complete a phase III study in the treatment of HCC. Signed a cooperation agreement with a sponsor to complete a phase II study in the treatment of SCCHN. Signed a contract for a phase Ib/II gastric or GEJ adenocarcinoma project.

  • Oct 2019

    The clinical monitoring time management system Time Sheet V1.0 goes online

  • Nov 2019

    Signed the agreement for a phase III NSCLC project. The Smart Technology Driven Oncological Clinical Trial Process Workshop and 2019 Fourth Quarter Zhangjiang Life Sciences Conference is successfully held.

  • Dec 2019

    eDISC system is delivered in the first center to carry out SMO service

    Signed a cooperation agreement with a sponsor to complete a phase III study in the treatment of HCC. Signed the agreement for the phase III NSCLC project. This project is the first in which Union Image used the Dual Oncological Evaluation Criteria.

  • Jan 2020

    Independent radiology review committee (IRC) system U-Orbit V1.1 goes online

    Successfully received ISO 9001 quality management system certification

    Signed a cooperation agreement with a sponsor to complete a phase II study in the treatment of HCC. Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of advanced solid tumors. 

  • Aug 2020

    Expanded laboratory business

    Developed FSP service

  • Sep 2020

    Complete the round A financing of more than 100 million

  • Oct 2020

    Acquisition of START

  • Dec 2020

    Completed system delivery of multiple centers

  • May 2020

    Complete the round A+ financing of more than 100 million

Clinical Expert Resources

Unionlab make the very solid cooperation with over 10 domestic core PI in oncology, including liver cancer, breast cancer, pancreatic cancer, head and neck cancer, stomach cancer, intestinal cancer, lung cancer, hematological tumor and others.


IRC specialist team


Unionlab has established a team of over 50 senior image review specialists from hospitals specializing in grade 3A cancer. They have a rich experience in reviewing images from new drug clinical trials for pharmaceutical companies with domestic and MNC. The team members have all been able to undergo serial induction training and pre-enrolment directed training. 

Clinical Research Centers

The smart clinical trial system has been delivered to numerous centers and has been operation.

Unionlab has been make the cooperation with 260 investigators and cover 200 clinical research centers, distribute 54 cities in China.

There are 11 hospitals in the US that we have been built the cooperation.